Michael R Pranzatelli

Neurology University of Central Florida, Orlando, FL, United States 
"Michael Pranzatelli"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pranzatelli MR, Tate ED, McGee NR, et al. (2018) Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome. Pediatric Neurology
Pranzatelli MR, Tate ED, McGee NR. (2018) Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US children. Pediatric Blood & Cancer. e27097
Pranzatelli MR, McGee NR, Tate ED. (2018) Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS. Journal of Neuroimmunology
Pranzatelli MR, Allison TJ, Tate ED. (2018) Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot study. European Journal of Paediatric Neurology : Ejpn : Official Journal of the European Paediatric Neurology Society
Pranzatelli MR, Allison TJ, McGee NR, et al. (2018) Cerebrospinal fluid γδ T cell frequency is age-related: a case control study of 435 children with inflammatory and non-inflammatory neurologic disorders. Clinical and Experimental Immunology
Pranzatelli MR, McGee NR. (2018) Neuroimmunology of OMS and ANNA-1/anti-Hu paraneoplastic syndromes in a child with neuroblastoma. Neurology(R) Neuroimmunology & Neuroinflammation. 5: e433
Pranzatelli MR, Tate ED. (2018) Corrigendum to "Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome" [Pediatric Neurology 73 (2017) 48-56]. Pediatric Neurology. 78: 84
Pranzatelli MR, Tate ED, Alber M, et al. (2017) Rituximab, IVIg, and Tetracosactide (ACTH1-24) Combination Immunotherapy ("RITE-CI") for Pediatric Opsoclonus-Myoclonus Syndrome: Immunomarkers and Clinical Observations. Neuropediatrics
Bielekova B, Pranzatelli MR. (2017) Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping. Seminars in Pediatric Neurology. 24: 229-239
Pranzatelli MR, Tate ED, McGee NR. (2017) Microglial/macrophage markers CHI3L1, sCD14, and sCD163 in CSF and serum of pediatric inflammatory and non-inflammatory neurological disorders: A case-control study and reference ranges. Journal of the Neurological Sciences. 381: 285-290
See more...